ROCHE HLDG LTD SPONS | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (52)

View All

Latest Posts

About This Stock More About This Stock
Q2 Earnings Scorecard And Analyst Reports
Article By: Sheraz Mian
Tuesday, July 18, 2023 11:06 PM EDT
We now have Q2 results from 38 S&P 500 members.
In this article: AMD, FMX, RHHBY, SPY
Read
Week In Review: BlissBio Announces Potential $2 Billion Deal With Eisai For HER2 ADC
Article By: ChinaBio® Today
Saturday, May 13, 2023 3:00 PM EDT
Bliss Biopharma may out-license global rights for its HER2 ADC to Eisai Pharma in a deal with a potential value of $2 billion. Also, Junshi Bio out-licensed regional rights for its anti-PD-1 mAb to Dr. Reddy’s Labs in a deal worth up to $728 million.
In this article: ESAIY Also: RDY, RHHBY, ACOR, LIAN, EQRX, IVBXF, CSPHF
Read
Biogen To Report Q1 Earnings: Here's What To Expect
Article By: Zacks Investment Research
Friday, April 21, 2023 12:33 PM EDT
We expect Biogen to beat expectations when it reports first-quarter 2023 results on Apr. 25 before the market opens. In the last reported quarter, the company delivered an earnings surprise of 15.38%.
In this article: BIIB Also: RHHBY
Read
Biogen Beats Q4 Earnings & Sales Estimates, Stock Up
Article By: Zacks Investment Research
Wednesday, February 15, 2023 10:50 AM EDT
Biogen reported fourth-quarter 2022 adjusted earnings per share (EPS) of $4.05.
In this article: BIIB Also: RHHBY
Read
Biogen To Report Q3 Earnings: Here's What To Expect
Article By: Zacks Investment Research
Friday, October 21, 2022 2:36 PM EDT
Biogen will report third-quarter 2022 results on Oct 25, before market open.
In this article: BIIB Also: RHHBY
Read
All Posts

Latest Tweets for $RHHBY

No tweets yet!

PARTNER HEADLINES